Albania
Bośnia i Hercegowina
Bułgaria
Chorwacja
Cypr
Czarnogóra
Czechy
Dania
Estonia
Hiszpania
Kosowo
Litwa
Łotwa
Luksemburg
Macedonia
Niemcy
Polska
Portugalia
Rumunia
Serbia
Słowacja
Słowenia
Szwajcaria
Szwecja
Turcja
Węgry
Wielka Brytania
Włochy
UAE
Hong Kong
Kuwejt
Liban
RPA
Terapie
komórkami macierzystymi
Terapie komórkami macierzystymi
Celem bankowania komórek macierzystych jest ich późniejsze wykorzystanie w terapii. Krew pępowinowa została zastosowana po raz pierwszy w 1988 roku, a od tego czasu – zgodnie z dostępnymi danymi – komórki macierzyste zostały użyte na świecie ponad 85 000 razy (łącznie ze statystykami z Chin).
Grupa FamiCord przechowuje ponad 1 000 000 porcji komórek różnych typów i dostarczyła komórki macierzyste do zastosowań klinicznych dla ponad 7000 pacjentów. Dostarczamy komórki do standardowych przeszczepień (z krwi pępowinowej, szpiku kostnego i mobilizowanej krwi obwodowej) oraz do terapii komórkowych. Ponadto wytwarzamy produkty komórkowe w standardzie GMP (ang. Good Manufacturing Practice) do badań klinicznych.
Komórki macierzyste pochodzące z naszych laboratoriów były wykorzystywane w leczeniu pacjentów z chorobami i wskazaniami z różnych obszarów terapeutycznych – m.in. hematologii, neurologii, okulistyki, ortopedii i dermatologii.
Sprawdź pełną listę pacjentów, którzy otrzymali terapię komórkami macierzystymi pochodzącymi z laboratoriów Grupy FamiCord.
Data aktualizacji: 06.2026
Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord
| Lp. | Źródło | Typ źródła | Wskazanie | Obszar medycyny | Rok podania | Terapia | Kraj | Wiek odbiorcy |
|---|---|---|---|---|---|---|---|---|
| 3501 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3502 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3503 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3504 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3505 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3506 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3507 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | 0 |
| 3508 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3509 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3510 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3511 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3512 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3513 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | 0 |
| 3514 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | 0 |
| 3515 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | 0 |
| 3516 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | 0 |
| 3517 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 5 |
| 3518 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 9 |
| 3519 | Cord Blood | Allogeneic – Related | Autism | Neurology | 2021 | Experimental Therapy | Poland | 7 |
| 3520 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4 |
| 3521 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Romania | 3 |
| 3522 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Romania | 5 |
| 3523 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 7 |
| 3524 | Cord Blood | Allogeneic – Related | Autism | Neurology | 2021 | Experimental Therapy | Germany | 8 |
| 3525 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 9 |
| 3526 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 7 |
| 3527 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 6 |
| 3528 | Cord Blood | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 9 |
| 3529 | Cord Blood | Allogeneic – Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 6 |
| 3530 | Cord Blood | Allogeneic – Related | Diamond Blackfan Anemia | Hematology | 2021 | Standard Therapy | Turkey | 3 |
| 3531 | Cord Blood | Autologous | Fanconi Anemia | Hematology | 2021 | Standard Therapy | Germany | 7 |
| 3532 | Cord Blood | Allogeneic – Related | Immune Failure-Cd40 L Deficiency | Hematology | 2021 | Standard Therapy | Turkey | 12 |
| 3533 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 5 |
| 3534 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 16 |
| 3535 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 7 |
| 3536 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 16 |
| 3537 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Slovakia | 4 |
| 3538 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 3539 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 33 |
| 3540 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 3541 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 3542 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 3543 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3544 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
| 3545 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 3546 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 3547 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 3548 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3549 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 3550 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3551 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 3552 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
| 3553 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3554 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 3555 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 34 |
| 3556 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3557 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 36 |
| 3558 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 39 |
| 3559 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 71 |
| 3560 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3561 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 3562 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 3563 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 52 |
| 3564 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 3565 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 50 |
| 3566 | Bone Marrow Family | Allogeneic | Refractory Cytopenia | Hematology | 2021 | Standard Therapy | Poland | 45 |
| 3567 | Bone Marrow Family | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 3568 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 11 |
| 3569 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
| 3570 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 3571 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 8 |
| 3572 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 3573 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 11 |
| 3574 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
| 3575 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 3576 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 3577 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 3578 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 3579 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 3580 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3581 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 3582 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3583 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 3584 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3585 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
| 3586 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
| 3587 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 15 |
| 3588 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3589 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Metabolic | 2021 | Standard Therapy | Poland | 8 |
| 3590 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 3591 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 19 |
| 3592 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 49 |
| 3593 | Bone Marrow | Allogeneic | Aplastic Anemia; Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 3594 | Bone Marrow | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 16 |
| 3595 | Bone Marrow | Allogeneic | Bcr-Abl Pos. All | Hematology | 2021 | Standard Therapy | Poland | 51 |
| 3596 | Bone Marrow | Allogeneic | Beta Thalassemia Major | Hematology | 2021 | Standard Therapy | Poland | 14 |
| 3597 | Bone Marrow | Allogeneic | Cartilage Hair Hypoplasia | Orthopedics | 2021 | Standard Therapy | Poland | 7 |
| 3598 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 3599 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 3600 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 2 |